Healthcare >> CEO Interviews >> October 13, 1997
JON D. LINDJORD assumed the position of Chief Executive Officer and
President effective August 1, 1995 and was elected a Director of
Atlantic effective December 5, 1995. From 1988 to 1994, Mr. Lindjord
worked for G.D. Searle in a variety of positions including Vice
President-Corporate Marketing, Vice President-Interna-tional Marketing
Operations, and most recently as Managing Director-Eastern Europe and
Russia. During the period from 1985 to 1988, Mr. Lindjord successfully
instituted a new department at Pfizer Pharmaceuticals with the role of
optimizing two-way communications between the marketing, licensing and
business units at the New York City headquarters and the research and
development division in Groton, Connecticut. During 1984 to 1985, Mr.
Lindjord served as Director of Business Development-Medicinal Products
at Bristol-Myers International Group. During the period 1977 to 1984,
Mr. Lindjord worked in a variety of sales, marketing research and
marketing positions for Pfizer Pharmaceuticals and Pfizer International.
From 1970 to 1977, Mr. Lindjord served as an officer in the U.S. Army,
Field Artillery, in a variety of command and staff positions. Mr.
Lindjord currently serves as a director of Globalvest Management
Company. Mr. Lindjord received his A.B. from Princeton University in
1970 and his M.B.A. from the Darden School at the University of Virginia
in 1972. Profile
of Atlantic Pharmaceuticals, for the readers?
Mr. Lindjord: Atlantic Pharmaceuticals is a company focusing on
